Journal Article DKFZ-2026-00736

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Attract to kill: Exploring the potential of motility trapping as a novel treatment strategy for high-grade gliomas.

 ;  ;  ;  ;  ;  ;

2026
Oxford Univ. Press Oxford

Neuro-Oncology nn, nn () [10.1093/neuonc/noag067]
 GO

Abstract: High-grade gliomas (HGG) are notoriously hard to treat due to surgical limitations and resistance to systemic therapies, resulting in a dire prognosis. Tumor cell motility is a major contributor to treatment failure but simultaneously offers a therapeutic opportunity, utilizing a novel approach called 'motility trapping'. Motility trapping leverages chemotactic signals to redirect tumor cells to a location where local therapies can target them more effectively. This concept can be applied inward, drawing disseminating tumor cells back to the primary tumor, or outward, guiding them toward a more therapy-accessible location. While preclinical research demonstrates that motility trapping can influence tumor migration, clinical translation remains unestablished. To advance clinical applicability, four essential components must be considered: effective migratory stimuli, susceptible tumor cells, suitable delivery systems, and the influence of the tumor microenvironment. For each element, we review current knowledge and propose future directions to develop this innovative approach. In conclusion, redirecting HGG migration through motility trapping offers a transformative strategy that warrants further preclinical and translational investigation. It holds promise to synergize with a plethora of therapeutic strategies that are currently ineffective in brain tumors, and should be considered in the design of future therapies.

Keyword(s): chemotaxis ; high-grade glioma ; local therapy ; motility trapping ; tumor cell motility

Classification:

Note: #DKTKZFB26# / epub

Contributing Institute(s):
  1. B062 Pädiatrische Neuroonkologie (B062)
  2. DKTK HD zentral (HD01)
Research Program(s):
  1. 312 - Funktionelle und strukturelle Genomforschung (POF4-312) (POF4-312)

Appears in the scientific report 2026
Database coverage:
Medline ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Essential Science Indicators ; IF >= 15 ; JCR ; NationallizenzNationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Public records
Publications database

 Record created 2026-03-30, last modified 2026-03-31



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)